Compare AdaptHealth Corp (AHCO) vs Vanguard International High Dividend Yield ETF (VYMI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Vanguard International High Dividend Yield ETF — how do they compare? AdaptHealth Corp trades at $10.1 (market cap $1.38B), while Vanguard International High Dividend Yield ETF trades at $99.55. The key difference: Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | VYMI | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $13.38 | $101.60 |
52-Week Low | $8.68 | $79.76 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
VYMI, Vanguard's International High Dividend Yield ETF, trades at $100.285, up 1.02% today, with a bullish technical outlook from moving averages. The fund offers a diversified portfolio of international dividend stocks with a low 0.07% expense ratio and an estimated yield near 4%, attracting over $2 billion in inflows in 2026 according to The Motley Fool (2026-05-30). Recent news highlights its role in inflation protection and diversification away from U.S. tech concentration.
The outlook for VYMI is positive, driven by strong dividend growth, attractive valuations compared to U.S. markets, and investor demand for international income. Risks include currency fluctuations, economic stagnation in key regions, and competition from other dividend ETFs. Analyst sentiment is generally favorable, emphasizing its defensive qualities in uncertain macroeconomic environments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Vanguard International High Dividend Yield ETF
VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →
